An Unwarranted Attack On Rare Disease Research

Hearing a parent agonize over the plight of their child who suffers from a rare disease is heart wrenching. For these families, research into rare disease drugs hasn ’t come close to “reaching an extreme”.

Source: Forbes.com Healthcare News - August 28, 2018 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NYSE:PFE NYSE:NVS NASDAQ:SRPT NASDAQ:RARE Source Type: news